DCTH : Summary for Delcath Systems, Inc. - Yahoo Finance

U.S. Markets close in 3 hrs 35 mins

Delcath Systems, Inc. (DCTH)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.92+0.06 (+3.23%)
As of 12:02 PM EST. Market open.
People also watch:
CLSNCYCCAEZSAVEODRRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.86
Open1.84
Bid1.90 x 1300
Ask1.93 x 600
Day's Range1.80 - 1.97
52 Week Range1.35 - 9.60
Volume11,593
Avg. Volume137,242
Market Cap4.22M
Beta1.82
PE Ratio (TTM)-0.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire6 days ago

    Delcath Systems to Present at the 9th Annual LD Micro Main Event

    LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that ...

  • Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube22 days ago

    Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Delcath Systems, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Delcath Systems, Inc. – AngioDynamics, Inc., Insulet Corporation, ICU Medical, Inc., Merit Medical Systems, Inc., Tandem Diabetes Care, Inc., Baxter International Inc. and Teleflex Incorporated (ANGO-US, PODD-US, ICUI-US, ... Read more (Read more...)

  • PR Newswire25 days ago

    Delcath Announces Third Quarter Financial Results

    NEW YORK, Nov. 11, 2016 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results ...